Though ocular hypertension may be the only modifiable risk factor for glaucoma, the second-leading cause of sight loss in the United Kingdom, monitoring for ocular hypertension more than twice a year is not efficient, researchers said.
Cataract surgery lowers IOP in eyes with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG), and it might even change the natural history of glaucoma in eyes with XFS. However, it may also be appropriate to combine phacoemulsification with glaucoma surgery in certain patients with XFG.
CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to the manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.
One-year after implantation of the Cypass Micro-Stent, study results demonstrate a reduction in IOP and glaucoma medications, as well as a complete lack of sight-threatening adverse events. The implant is placed into the supraciliary space to facilitate suprachoroidal aqueous outflow in glaucoma patients.